Back to Search
ALEXANDRA LOCKHART, PHARMD
PHARMD
Pharmacist
NPI: 1497575484Individual
Specialties, Licenses & Credentials
Research & Publications (20)
A phase I dose-escalation study of SR271425, an intravenously dosed thioxanthone analog, administered weekly in patients with refractory solid tumors.
PMID 19194116·Am J Clin Oncol·2009
3-trial
Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors.
PMID 17091249·Cancer Chemother Pharmacol·2007
3-trial
Phase I/pilot study of SU5416 (semaxinib) in combination with irinotecan/bolus 5-FU/LV (IFL) in patients with metastatic colorectal cancer.
PMID 16601426·Am J Clin Oncol·2006
3-trial
Imaging Alzheimer's disease pathology: one target, many ligands.
PMID 17129828·Drug Discov Today·2006
6-review
Treatment for pancreatic cancer: current therapy and continued progress.
PMID 15887156·Gastroenterology·2005
6-review
The epidermal growth factor receptor as a target for colorectal cancer therapy.
PMID 15726506·Semin Oncol·2005
6-review
A phase I dose-escalation and pharmacokinetic study of brostallicin (PNU-166196A), a novel DNA minor groove binder, in adult patients with advanced solid tumors.
PMID 14760067·Clin Cancer Res·2004
3-trial
Pharmacogenetics of ATP-binding cassette transporters in cancer and chemotherapy.
PMID 12883042·Mol Cancer Ther·2003
6-review
Novel targets in esophageal and gastric cancer: beyond antiangiogenesis.
PMID 19642951·Expert Opin Investig Drugs·2009
6-review
Monitoring the amyloid beta-peptide in vivo--caveat emptor.
PMID 19135168·Drug Discov Today·2009
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2021 E LARAWAY RD
NEW LENOX, IL 60451 - Phone
- (815) 463-4954
Quick Facts
- NPI
- 1497575484
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile